AlphaGrep UK
REGN icon

AlphaGrep UK’s Regeneron Pharmaceuticals REGN Stock Holding History

AlphaGrep UK’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$594K Sell
783
-1,160
-60% -$877K 0.18% 169
2026
Q2 		$1.21M Buy
1,943
+1,659
+584% +$1.13M 0.36% 24
2026
Q1 		$219K Buy
284
+10
+4% +$7.66K 0.06% 683
2025
Q4 		$211K Buy
+274
New +$186K 0.07% 607

Other funds holding REGN

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

AlphaGrep UK's REGN Position: Q3 2026 in Review

AlphaGrep UK reduced its Regeneron Pharmaceuticals (REGN) stake by 60% in Q3 2026, selling an estimated $877K and leaving 783 shares worth $594K. The position accounts for 0.18% of the portfolio, ranked #169.

AlphaGrep UK first reported a position in REGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.21M in Q2 2026. 1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • AlphaGrep UK held 783 shares of Regeneron Pharmaceuticals worth $594K as of Q3 2026.
  • AlphaGrep UK sold 1,160 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $877K.
  • Regeneron Pharmaceuticals made up 0.18% of AlphaGrep UK's portfolio in Q3 2026, its #169 holding.
  • AlphaGrep UK first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • AlphaGrep UK's Regeneron Pharmaceuticals position peaked at $1.21M in Q2 2026.
  • 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.